“We are driven by the
conviction that no disease,
including cancer, is beyond
a cure.”
Accanito presents a unique mechanism of action.
Our Mission
“Our mission is to advance breakthrough cancer therapies that bring hope and make a real impact for patients worldwide. We combine scientific excellence, exceptional innovation, and disciplined execution to develop treatments that change the trajectory of cancer — creating meaningful value for patients, care providers, and investors.”
About GAM-05
GAM 05 is a first-in-class, mitochondria-targeted HSP inhibitor designed to selectively accumulate in tumor mitochondria, disrupt mitochondrial energy pathways, and induce irreversible cancer cell death. With tumor selective uptake, a differentiated mechanism, and strong preclinical efficacy, GAM-05 offers a compelling competitive edge as a platform-level oncology asset.
Our Leadership Team
Dr Umar Hayat
Founder & CEO
Dario C. Altieri, M.D
Co Founder
“Innovating the Future of Cancer Treatment.”
Every breakthrough in cancer research brings new hope to millions of patients around the world.
Targeting Cancer at its Core
Targeted Mitochondrial Therapy
We are pioneering a novel class of anticancer therapeutics that selectively target mitochondrial function in cancer cells. By disrupting tumor-specific energy metabolism, our approach induces apoptosis while minimizing damage to healthy tissues—offering a differentiated and precise treatment strategy.
Scalable Drug Development
Our platform is designed to accelerate the development of mitochondrial-targeting compounds from discovery to clinical validation. With a focus on robust preclinical models and translational efficiency, we aim to deliver high-value assets with strong commercialization potential.
Transforming Cancer Treatment Outcomes
We are committed to redefining cancer care through mechanism-driven innovation. Our therapies aim to overcome resistance, improve patient survival, and enhance quality of life—addressing critical unmet needs across oncology.
.
A new era in cancer treatment begins with Gam-05. Discover the investment potential.
Our Core Values
Driving Innovation in the Fight Against Cancer
Innovation
We develop cutting-edge oncology therapeutics through advanced research and scientific excellence.
Collaboration
We believe breakthrough discoveries happen through strong partnerships and teamwork.
Sustainability
We are committed to responsible research and sustainable healthcare solutions.
Integrity
We uphold the highest ethical standards in every stage of drug development.
Excellence
We strive for precision, quality, and excellence in everything we do.
Commitment
We are dedicated to improving lives through continuous innovation in cancer treatment.
News and Updates
Latest News & Updates
Bringing Hope to Every Cancer Patient
We are committed to developing innovative therapies that improve survival, enhance quality of life, and redefine the future of cancer care.